We produce highly efficient therapeutic cells; Methylation Induced Pluripotent Cells (MIPC) for immune- and regenerative therapies. Few milliliters of peripheral blood are enough to produce one hundred times more therapeutic cells than from other sources. MIPCs are made from autologous, heterologous or xenographic sources. MIPCs can adopt to any type of infection with an immediate treatment effect in case of serious pandemics. Cells for this purpose are made from xenographic sources.

Therapeutic applications include Liver cirrhosis, Heart, Lung, and Kidney insufficiency, Neonatal hypoxia, Alzheimer, skin re-juvenation, post covid syndrome, Joints Arthritis, Diabetes side effects, fast wound healing and as an alternative for bone marrow transplantation.

Ophthalmology applications include Limbal stem cell deficiency, Ocular pemphigoid, Steven Johnson syndrome, Optic nerve atrophy, Behcet disease, Diabetic retinopathy, Retinal dystrophies, and Macular degeneration.